HLCS: Summary for Helicos BioSciences Corporation - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 12:46am EST - Canadian Markets open in 8 hours and 44 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Helicos BioSciences Corporation (HLCS)

On Feb 9: 1.00 USD

0.01 (0.99%)

MORE ON HLCS

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Helicos BioSciences Corporation (NGM:HLCS) Delayed quote data

Last Trade:	1.00 USD
Trade Time:	Feb 9
Change:	0.01 (0.99%)
Prev Close:	1.01
Open:	0.99
Bid:	0.93 x 1000
Ask:	2.91 x 100
1y Target Est:	2.00

Day's Range:	0.99 - 1.01
52wk Range:	0.38 - 3.54
Volume:	243,608
Avg Vol (3m):	1,229,590
Market Cap:	72.96M
P/E (ttm):	N/A
EPS (ttm):	-0.56
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Add HLCS to Portfolio

Download Data

HEADLINES

•	Helicos Announces Additional System Installations for the St. Laurent Institute and Stanford University
	Business Wire (Wed, Feb 3)

•	Gene Machine Wars Get Ever Hotter
	at Forbes.com (Thu, Jan 28)

•	Helicos Introduces New Sequencing Kits to Enhance Versatility of the HeliScope Single Molecule Sequencer
	Business Wire (Tue, Jan 26)

•	Ballard Power, Enterra: Early Volume Plays
	at TheStreet.com (Tue, Jan 19)

•	Helicos BioSciences Announces the Sale of a Helicos® Genetic Analysis System to the Turku Centre for Biotechnology
	Business Wire (Tue, Jan 19)

•	New Illumina Genome Sequencer Dramatically Slashes Costs, Time
	at Seeking Alpha (Tue, Jan 19)

•	Illumina Unveils System to Cut Genome Sequencing Costs
	at The Wall Street Journal Online (Tue, Jan 12)

•	Illumina's Cheap New Gene Machine
	at Forbes.com (Tue, Jan 12)

•	Life Science Stocks: A Growing Market in 2010
	at BusinessWeek (Mon, Dec 28)

•	HELICOS BIOSCIENCES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Fi
	EDGAR Online (Fri, Dec 18)

•	Helicos registers for stock, warrant offering
	at bizjournals.com (Thu, Dec 17)

More Headlines for HLCS...

ANALYST

EPS Est (next year) (Dec-09) :	N/A
EPS Est (in 2 years) (Dec-10) :	-0.09
Avg Rec (current)*:	3.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Helicos BioSciences Corporation, a life sciences company, focuses on genetic analysis technologies for the research, drug discovery, and clinical diagnostics markets.

Full Company Profile

Add to Portfolio

Email to a Friend

•